CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode
The company reported revenue of €14.5 million for the fourth quarter, representing a decrease of €8.1 million from the corresponding period of 2023, and below an analyst estimate of €20.58, according...
Pharma Stocks Look Cheap. Here's One Way to Invest.
Last year’s projected healthcare spending growth rate of 7.5% outpaced GDP growth for the first time since the pandemic. As an aging population creates more demand for medical care, it opens up opportunities...